Attenello, F. J., D. Mukherjee, G. Datoo, M. J. McGirt, E. Bohan, J. D. Weingart, A. Olivi, A. Quinones-Hinojosa, and H. Brem. 2008. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: A 10-year institutional experience. Annals of Surgical Oncololgy 15(10):2887–2893.
Barinaga, M. 1999. Genentech, UC Settle Suit for $200 Million. Science 286(5445):1655.
Brennan, T. A., D. J. Rothman, L. Blank, D. Blumenthal, S. C. Chimonas, J. J. Cohen, J. Goldman, J. P. Kassirer, H. Kimball, J. Naughton, and N. Smelser. 2006. Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. Journal of the American Medical Association 295(4):429–433.
Chaichana, K. L., P. Zadnik, J. D. Weingart, A. Olivi, G. L. Gallia, J. Blakeley, M. Lim, H. Brem, and A. Quinones-Hinojosa. 2013. Multiple resections for patients with glioblastoma: Prolonging survival. Journal of Neurosurgery 118(4):812–820.
DiMasi, J. A., R. W. Hansen, and H. G. Grabowski. 2003. The price of innovation: New estimates of drug development costs. Journal of Health Economics 22(2):151–185.
DOJ (U.S. Department of Justice). 2008. Merck to pay more than $650 million to resolve claims of fraudulent price reporting and kickbacks. Press release, February 7. Washington, DC: DOJ. http://www.usdoj.gov/opa/pr/2008/February/08_civ_094.html (accessed December 10, 2013).
HHS (Department of Health and Human Services). 2011. Responsibility of applicants for promoting objectivity in research for which Public Health Service funding is sought and responsible prospective contractors; final rule. Federal Register 76(165):53255–53293.
IOM (Institute of Medicine). 2008. Resident duty hours: Enhancing sleep, supervision, and safety. Washington, DC: The National Academies Press.
IOM. 2009. Conflict of interest in medical research, education, and practice. Washington, DC: The National Academies Press.
IOM. 2013. Sharing clinical research data: Workshop summary. Washington, DC: The National Academies Press.
IOM. 2014. Improving the efficiency and effectiveness of genomic science translation: Workshop summary. Washington, DC: The National Academies Press.
Krumholz, H. M., J. S. Ross, C. P. Gross, E. J. Emanuel, B. Hodshon, J. D. Ritchie, J. B. Low, and R. Lehman. 2013. A historic moment for open science: The Yale University Open Data Access Project and Medtronic. Annals of Internal Medicine 158(12):910–911.
Lichter, A. S., and R. McKinney. 2012. Toward a harmonized and centralized conflict of interest disclosure: Progress from an IOM initiative. Journal of the American Medical Association 308(20):2093–2094.
Lichter, A., R. McKinney, T. Anderson, E. Breese, N. Brennan, D. Butler, E. Campbell, S. Chimonas, G. Chisolm, C. Clark, M. Corn, A. Coukell, D. Dean, S. Eringhaus, P. Fontanarosa, M. Frankel, R. Hutchinson, T. Jost, N. Kahn, C. Laine, M. LaLonde, L. Lynn, P. McCormick, P. Miller, H. Pierce, J. Hartzler Warner, P. Weber, D. Zuk, A. C. Berger, and I. Von Kohorn. 2012. Harmonizing reporting on potential conflicts of interest: A common disclosure process for health care and life sciences, Discussion Paper, Institute of Medicine, Washington, DC. http://www.iom.edu/COIperspective (accessed December 9, 2013).
Lockhart, A. C., M. S. Brose, E. S. Kim, D. H. Johnson, J. M. Peppercorn, D. L. Michels, C. D. Storm, L. M. Schuchter, and W. K. Rathmell. 2013. Physician and stakeholder perceptions of conflict of interest policies in oncology. Journal of Clinical Oncology 31(13):1677–1682.
Ornstein, C., and T. Weber. 2011. Heart society’s tip sheets fail to mention risks. ProPublica. http://projects.propublica.org/docdollars (accessed December 9, 2013).
Ornstein, C., T. Weber, and D. Nguyen. 2010. Docs on pharma payroll have blemished records, limited credentials. ProPublica. http://projects.propublica.org/docdollars (accessed December 9, 2013).
Palmer, R. 2010. Avandia update: Trial suspended, panelists conflicted, mechanism discovered. Spoon Full of Medicine: A blog from Nature Medicine. http://blogs.nature.com/spoonful/2010/07/avandia_update_trial_suspended.html (accessed December 10, 2013).
Paul, S. M., D. S. Mytelka, C. T. Dunwiddie, C. C. Persinger, B. H. Munos, S. R. Lindborg, and A. L. Schacht. 2010. How to improve R&D productivity: The pharmaceutical industry’s grand challenge. Nature Reviews Drug Discovery 9(3):203–214.
Rosenthal, M. B., and M. M. Mello. 2013. Sunlight as disinfectant—new rules on disclosure of industry payments to physicians. New England Journal of Medicine 368(22):2052–2054.
Thomas, K., and M. Schmidt. 2012. Glaxo agrees to pay $3 billion in fraud settlement. New York Times, July 3. http://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html?pagewanted=1&_r=2&nl=todaysheadlines&emc=edit_th_20120703& (accessed December 10, 2013).
Zinner, D. E., C. M. DesRoches, S. J. Bristol, B. Clarridge, and E. G. Campbell. 2010. Tightening conflict-of-interest policies: The impact of 2005 ethics rules at the NIH. Academic Medicine 85(11):1685–1691.